Trendy Stocks
OTLK Stock had a steady decline. Here’s why
Outlook Therapeutics Inc. (OTLK), a biopharmaceutical company, saw a decline of 8.71% in its share price on Wednesday. The shares were changing hands at $2.20.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.